NYC Gazette

A comprehensive review on atopic dermatitis, commonly known as eczema, has been published in The Lancet by a team of experts led by Dr. Emma Guttman-Yassky from Mount Sinai. This publication is described as a "seminar" and sheds light on the global impact of this chronic inflammatory skin disease, which affects over 200 million people worldwide.

Dr. Guttman-Yassky, who holds the Waldman Professorship and serves as System Chair of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai, co-authored the article with international dermatologists Patrick Brunner from Mount Sinai and Yael Renert-Yuval from Schneider Children’s Medical Center of Israel. The seminar offers an extensive overview of atopic dermatitis, its pathophysiology, and recent treatment advancements for both adults and children.

“It is an honor to contribute this seminar to The Lancet, which reflects Mount Sinai's leadership in advancing dermatological science and improving patient care,” stated Dr. Guttman-Yassky. “Our work provides a comprehensive understanding of the underlying mechanisms that have led to novel treatments for atopic dermatitis, with broad implications for the medical, allergy, and dermatological communities.”

Dr. Brunner emphasized the broader impact of atopic dermatitis: “We would like to stress that atopic dermatitis doesn’t just affect the skin—it can take a toll on emotional well-being and quality of life. This publication is a step forward in helping clinicians understand and treat this complex condition with the latest therapeutic advances.”

The Lancet is recognized globally for publishing high-quality research across various health disciplines. This review underscores Mount Sinai's leadership in researching eczema and its treatment options. The institution hosts a dedicated eczema center focusing on research, clinical trials, and patient care.

Atopic dermatitis presents symptoms such as red, itchy skin often associated with allergies or asthma history. It poses additional risks like increased susceptibility to other allergic conditions including asthma or food allergies. Recent scientific advancements have introduced new treatments such as biological drugs and Janus kinase inhibitors offering relief where traditional methods may not suffice.

Mount Sinai's Icahn School of Medicine is renowned for its research excellence and educational programs within one of America's largest academic health systems serving New York City's diverse population.

For more information about their dermatology department visit: https://icahn.mssm.edu/about/departments-offices/dermatology